Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Loss of material from chromosome region 1q24q25. | Extra copy of material at chromosome region 14q11.2. | High |
| Development and growth | Developmental delay and growth issues are described; exact pattern is not fixed. | Features vary and may include developmental delay, often recognized in early childhood. | Moderate |
| Reported severity | Source severity is severe, but individual course is not established here. | Source severity is moderate, with variable clinical features. | Low |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
A confirmed 1q24q25 deletion
The specific deletion, not symptoms alone, supports this diagnosis.
High
Developmental delay with growth concerns
These are described associations, but testing must confirm the cause.
Moderate
Counseling after a deletion result
Care is individualized because complications are not fully specified here.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
A confirmed 14q11.2 duplication
The extra chromosomal segment defines this condition.
High
Developmental concerns at ages 0–5 years
Source onset is early childhood, although overlap with other conditions is expected.
Moderate
Variable features without a deletion
Supportive care is reasonable while genetics interprets the finding.
Low
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss at 1q24q25. | May show copy-number gain at 14q11.2. | Locus and loss versus gain distinguish them; specialist review is required. |
| Karyotype | A small deletion may not be visible. | A small duplication may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical examination | Cannot independently prove the deletion. | Cannot independently prove the duplication. | Examination guides care but is not diagnostic. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Long-term outcome is not established; the source describes a severe chronic condition.
- Factors
- Deletion extent, associated findings, and developmental support may influence course.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is not established; the source describes moderate, chronic, variable features.
- Factors
- Duplication interpretation, developmental needs, and therapy access may matter.
Time frame: Lifelong follow-up; onset is variable on the left and often from birth to age 5 on the right.
Neither condition is communicable, and prognosis should be individualized.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental delay | Described, without specified domains or severity. May occur; expression varies. Early support may help, but outcomes are individual. |
| Growth concerns | Growth issues are described in the source. Not specifically established by the supplied source. Do not assume shared growth effects; monitor clinically. |
| Other medical problems | Various concerns are mentioned without a fixed list. Specific complications are not established here. Evaluate and manage identified findings individually. |
Patient education highlights
- HighGenetic distinction
The chromosome region and whether material is missing or extra separate these conditions.
- HighCare approach
Management is supportive and individualized; no treatment dose or cure is established here.
- MediumVariable course
Features differ between people. A clinician should interpret results and arrange follow-up.